Therapeutic options forAcinetobacter baumanniiinfections

This publication has 113 references indexed in Scilit:

• Colistin Heteroresistance in Acinetobacter and Its Association with Previous Colistin Therapy
  Antimicrobial Agents and Chemotherapy, 2008
• Antimicrobial activity of tigecycline against clinical isolates from Spanish medical centers. Second multicenter study
  Diagnostic Microbiology and Infectious Disease, 2006
• Activity of Cecropin A-Melittin Hybrid Peptides against Colistin-Resistant Clinical Strains of Acinetobacter baumannii : Molecular Basis for the Differential Mechanisms of Action
  Antimicrobial Agents and Chemotherapy, 2006
• Outbreak of Infection WithAcinetobacterStrain RUH 1139 in an Intensive Care Unit
  Infection Control & Hospital Epidemiology, 2006
• Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of Acinetobacter baumannii
  Journal of Antimicrobial Chemotherapy, 2004
• Presence of the Tet M Determinant in a Clinical Isolate of Acinetobacter baumannii
  Antimicrobial Agents and Chemotherapy, 2003
• Cerebrospinal Fluid Penetration and Pharmacokinetic/Pharmacodynamic Parameters of Intravenously Administered Colistin in a Case of Multidrug-Resistant Acinetobacter baumannii Meningitis
  European Journal of Clinical Microbiology & Infectious Diseases, 2002
• Cloning, Nucleotide Sequencing, and Analysis of the Gene Encoding an AmpC β-Lactamase in Acinetobacter baumannii
  Antimicrobial Agents and Chemotherapy, 2000
• Antimicrobial susceptibility of clinical isolates of Acinetobacter baumannii
  Diagnostic Microbiology and Infectious Disease, 1996
• In-vitro andin-vivo activities of antimicrobial agents againstAcinetobacter calcoaceticus
  Journal of Antimicrobial Chemotherapy, 1985